These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial. Lee JG, Shin BS, Lee YC, Park SW, Kim YH. Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029 [Abstract] [Full Text] [Related]
53. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population. Cohen S, Khan A, Zheng Y, Chiles J. Acta Psychiatr Scand; 1991 Mar 15; 83(3):234-7. PubMed ID: 1674398 [Abstract] [Full Text] [Related]
54. Olanzapine for the treatment of tardive dyskinesia. Almeida OP. J Clin Psychiatry; 1998 Jul 15; 59(7):380-1. PubMed ID: 9714267 [No Abstract] [Full Text] [Related]
58. Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs. Am J Psychiatry; 1980 Oct 15; 137(10):1163-72. PubMed ID: 6106389 [Abstract] [Full Text] [Related]